Načítá se...
Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system
PURPOSE: Transthyretin-mediated hereditary amyloidosis (hATTR amyloidosis) is a multisystemic disease with heterogeneous clinical presentation. Hallmarks of the disease are sensory-motor and autonomic neuropathy and cardiomyopathy. Two disease-modifying drugs, inotersen (an antisense oligonucleotide...
Uloženo v:
| Vydáno v: | Clin Auton Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763402/ https://ncbi.nlm.nih.gov/pubmed/31399774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10286-019-00626-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|